SPIRITUS: (05-18) A Monthly update from the Respiratory Technology team at the WIMR.

May.png

This is the May 2018 newsletter from the RespiTech Group at the Woolcock Institute of Medical Research.

This month Dr Maliheh Ghadiri was awarded the Woolcock Postdoctoral Fellowship. The Woolcock Postdoctoral Fellowship is highly competitive externally advertised Postdoctoral Fellowship that provides two years salary support for an early career researcher to undertake cutting edge medical research at the Woolcock Institute of Medical Research. Congratulations Mali!


 
 Dr Maliheh Ghadiri awarded Woolcock Postdoctorate Fellowship

Dr Maliheh Ghadiri awarded Woolcock Postdoctorate Fellowship

 

Also this month, Daniela Traini was invited to talk about her life as a Italian Scientist immigrating to Australia. Daniela spoke at the Italian Forum in Sydney about her Research in Medicine and at the Woolcock on treating lung diseases.

 
 Daniela talks about her life as a Italian and Australian Scientist at the Forum, Leichhardt, Sydney.

Daniela talks about her life as a Italian and Australian Scientist at the Forum, Leichhardt, Sydney.

 

Members of the Respitech team, awarded a grant for building a pharmaceutical manufacturing company have finally located a site for the new company, Ab-Initio. Hui Xin Ong (YY) Daniela Traini and Paul Young, CIs on the grant have located a premises near the University and Sydney Local Health District RPA campus. The next step is the design phase. Dr Michele Pozzoli is helping develop the requirements for the site in partnership with the University and SLHD.

As always, we give an update on Respitech Journal publications. This month Paul was a co-author on an article in the Journal of Allergy and Clinical Immunology (JACI). The lead author was Professor Lisa Wood (School of Biomedical Sciences and Pharmacy at the University of Newcastle, Australia) and the article was titled "Saturated fatty acids, obesity, and the nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome in asthmatic patients."

Lastly with the increasing workload as the new Chair of Commercialisation in the new Faculty of Medicine and Health, Paul Young stepped down in his role as Deputy Executive Director of the Woolcock.